Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina

2008, 233 Jaffe, 2011, Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification, Hematology Am Soc Hematol Educ Program, 2011, 506, 10.1182/asheducation-2011.1.506 Aukema, 2011, Double-hit B-cell lymphomas, Blood, 117, 2319, 10.1182/blood-2010-09-297879 Snuderl, 2010, B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma, Am J Surg Pathol, 34, 327, 10.1097/PAS.0b013e3181cd3aeb Li, 2012, B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome, Mod Pathol, 25, 145, 10.1038/modpathol.2011.147 Paternoster, 2002, A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization, Am J Pathol, 160, 1967, 10.1016/S0002-9440(10)61146-7 Petersen, 2004, Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method, Appl Immunohistochem Mol Morphol, 12, 259, 10.1097/00129039-200409000-00013 de Leval, 2009, Diffuse large B-cell lymphomas and burkitt lymphoma, Hematol Oncol Clin North Am, 23, 791, 10.1016/j.hoc.2009.04.004 Nakamura, 2002, The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement, Mod Pathol, 15, 771, 10.1097/01.MP.0000019577.73786.64 Kanungo, 2006, Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis, Mod Pathol, 19, 25, 10.1038/modpathol.3800500 Chuang, 2007, Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH, Am J Clin Pathol, 128, 558, 10.1309/EQJR3D3V0CCQGP04 Niitsu, 2009, Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations, Leukemia, 23, 777, 10.1038/leu.2008.344 Choi, 2009, A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy, Clin Cancer Res, 15, 5494, 10.1158/1078-0432.CCR-09-0113 Savage, 2009, MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy, Blood, 114, 3533, 10.1182/blood-2009-05-220095 Rosenwald, 2008, Ann Oncol, 19, iv67, 10.1093/annonc/mdn201 Sevilla, 2007, Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation, Am J Clin Pathol, 128, 981, 10.1309/C1PP15P7CDB8UY39 Haralambieva, 2005, Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma, Am J Surg Pathol, 29, 1086, 10.1097/01.pas.0000168176.71405.e5 Carbone, 2010, B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology., Hum Pathol, 41, 621, 10.1016/j.humpath.2009.10.027 Kurita, 2011, A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma, J Clin Exp Hematop, 51, 37, 10.3960/jslrt.51.37 McClure, 2005, Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior, Am J Surg Pathol, 29, 1652, 10.1097/01.pas.0000180442.87022.08 Le Gouill, 2007, The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement, Haematologica, 92, 1335, 10.3324/haematol.11305 Salaverria, 2011, The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective, J Clin Oncol, 29, 1835, 10.1200/JCO.2010.32.8385 Tomita, 2009, Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations, Haematologica, 94, 935, 10.3324/haematol.2008.005355 Tomita, 2011, BCL2 and MYC dual-hit lymphoma/leukemia, J Clin Exp Hematop, 51, 7, 10.3960/jslrt.51.7 Johnson, 2009, Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival, Blood, 114, 2273, 10.1182/blood-2009-03-212191 Bellan, 2010, Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach, Hematol Oncol, 28, 53 Lin, 2012, Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma, Cancer, 118, 1566, 10.1002/cncr.26433 Ahn, 2012, A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child, Ann Lab Med, 32, 162, 10.3343/alm.2012.32.2.162 Hoeller, 2012, Grey zone lymphomas: lymphomas with intermediate features, Adv Hematol, 2012, 460801, 10.1155/2012/460801 Frick, 2012, New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma, Best Pract Res Clin Haematol, 25, 3, 10.1016/j.beha.2012.01.003 Chen, 2010, Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms, Mod Pathol, 23, 105, 10.1038/modpathol.2009.140 Dictor, 2009, Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma, Haematologica, 94, 1563, 10.3324/haematol.2009.008474 Vegliante, 2011, Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications, PLoS One, 6, e21382, 10.1371/journal.pone.0021382 Macpherson, 1999, Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation, J Clin Oncol, 17, 1558, 10.1200/JCO.1999.17.5.1558